MKI67 and neoplasm: In addition, compared with the other groups, the ICAM‐1–Dxd plus B7‐H3‐CD3 group presented a significantly reduced number of Ki67‐positive cells, leading to substantial and sustained inhibition of tumor growth (Figure 8G).